on Theranexus (EPA:ALTHX)
Theranexus Announces its Financial Agenda for 2025
Biopharmaceutical company Theranexus, which specializes in rare neurological diseases, has published its financial calendar for 2025. The dates communicated concern key financial publications that will take place after the close of trading on Euronext Paris. Theranexus specifies that these dates could be modified if necessary.
The proposed timetable starts with the announcement of the cash position as of December 31, 2024, scheduled for February 13, 2025. The 2024 annual financial results will be revealed on April 29. The general meeting is scheduled for June 26, followed by mid-year cash position publications on July 10 and half-year results on September 25. Finally, the cash position as of September 30, 2025 will be announced on October 23.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Theranexus news